Viewing StudyNCT00521365



Ignite Creation Date: 2024-05-05 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00521365
Status: COMPLETED
Last Update Posted: 2012-07-17
First Post: 2007-08-24

Brief Title: Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: D1443L00017
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators